MaaT Pharma Announces U.S. FDA Lifts Clinical Hold on Phase 3 Investigational New Drug Application for MaaT013 in Patients with Acute Graft-versus-Host Disease Read more about MaaT Pharma Announces U.S. FDA Lifts Clinical Hold on Phase 3 Investigational New Drug Application for MaaT013 in Patients with Acute Graft-versus-Host Disease
Sensorion to Host a Symposium during ISIET’s International Symposium on Inner Ear Therapeutics on April 30, 2023 Read more about Sensorion to Host a Symposium during ISIET’s International Symposium on Inner Ear Therapeutics on April 30, 2023
Consequences of the Viridor offer declared unconditional – Plan to call for Extraordinary General Meeting Read more about Consequences of the Viridor offer declared unconditional – Plan to call for Extraordinary General Meeting
Nicox: 2023 Ordinary Shareholder Meeting to be held on June 1st, 2023 Read more about Nicox: 2023 Ordinary Shareholder Meeting to be held on June 1st, 2023
Viridor announces conditions fulfilled or waived for voluntary recommended cash offer to acquire all shares in Quantafuel ASA – final extension of offer period Read more about Viridor announces conditions fulfilled or waived for voluntary recommended cash offer to acquire all shares in Quantafuel ASA – final extension of offer period
Asetek A/S - Start of subscription period for the Rights Issue Read more about Asetek A/S - Start of subscription period for the Rights Issue
Tikehau Capital: Disclosure of Shares Repurchases From 14 April to 20 April 2023 Read more about Tikehau Capital: Disclosure of Shares Repurchases From 14 April to 20 April 2023
Vår Energi reports first quarter 2023 results Read more about Vår Energi reports first quarter 2023 results